申请人:Epizyme, Inc.
公开号:US20140315904A1
公开(公告)日:2014-10-23
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.
本文描述了公式(I)的化合物,其药学上可接受的盐及其制药组合物。本文所描述的化合物可用于抑制精氨酸甲基转移酶活性。还描述了使用这些化合物治疗精氨酸甲基转移酶介导的疾病的方法。